Acrivon Therapeutics, Inc.
Ticker: ACRV
| Insider | Title |
|---|---|
| Advisors Llc Perceptive | 10% or greater ownership |
| Anastasis Nikolaou | 10% or greater ownership |
| Andreas Hadjimichael | 10% or greater ownership |
| Biomedical Innovation Master Investors (cayman) I L.p. Wellington | 10% or greater ownership |
| Capital Healthcare Fund Lp Ra | Director, 10% or greater ownership |
| Capital Management, L.p. Ra | Director, 10% or greater ownership |
| Capital Nexus Fund Ii, L.p. Ra | Director |
| Charles M Baum | Director |
| Derek Dirocco | Director |
| Eric Devroe | Chief Operating Officer |
| Erick Gamelin | Chief Development Officer |
| Ivana Magovcevic-liebisch | Director |
| Jean-marie Cuillerot | Chief Medical Officer |
| Joseph Edelman | 10% or greater ownership |
| Katharine Peterson | Chief Accounting Officer |
| Kristina Masson | EVP - Business Operations, Director |
| Life Sciences Master Fund Ltd Perceptive | 10% or greater ownership |
| Ltd Chione | 10% or greater ownership |
| Marcin Czernik | 10% or greater ownership |
| Mary Miller | Chief Legal Officer |
| Michael John Tomsicek | Director |
| Peter Blume-jensen | President and CEO, Director |
| Peter Kolchinsky | Director, 10% or greater ownership |
| Rajeev M. Shah | Director, 10% or greater ownership |
| Rasmus Holm-jorgensen | Chief Financial Officer |
| Santhosh Palani | Director |
| Sharon Shacham | Director |
| Wiaczeslaw Smolokowski | 10% or greater ownership |